Abstract
Over the past three decades, strictureplasty for Crohn disease with fibrostenotic
stricture has been shown to be both efficacious and safe. Although segmental resection
remains the standard of care for obstruction secondary to Crohn stricture, strictureplasty
should be considered for patients with a history of prior resections who are at increased
risk for short bowel syndrome with additional resections. There is ample evidence
to support both conventional and nonconventional strictureplasty techniques for both
jejunoileal and ileocolonic anastomotic strictures. The role of strictureplasty for
both duodenal and colonic disease, as well as the risk of malignant transformation
at strictureplasty sites, is yet to be determined.
Keywords
strictureplasty - Crohn disease - stricture - obstruction
